ISR Immune System Regulation Holding AB (publ) 6,12
0,25%
ISR Immune System Regulation Holding AB (publ) researches and develops drugs for the treatment of viral infections in Sweden. The company's product pipeline includes Covid-19 vaccine, HBV, HIV, and oncology. The company is headquartered in Stockholm, Sweden. Læs mere
Kr. 421M Markedsværdi
- Omsætning
Bioteknologi Industri
Sverige Hjemland
israb.se Hjemmeside
Sundhed Sektor